Tag: life sciences
-
Trial Underway Testing Dried Plasma for Transfusions
A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma.
-
Bio-Friendly Plant Nutrient Delivery Patent Awarded
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent.
-
Digital Biomarkers Shown to Highlight Parkinson’s Disease
Early findings indicate calculations from MRI scans of white matter lesions in the brain can distinguish between Parkinson’s disease and other neurological conditions.
-
Biochip Device Tests Malaria Drug Efficacy, Safety
A lab-on-a-chip device with human organ cells is shown in lab tests to distinguish between malaria strains and detect drug toxicity when assessing blood for seven days.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.
-
Engineered T-Cells Shown Safe, Reduce Myasthenia Gravis
Results of a small clinical trial show genetically altered T-cells from patients with myasthenia gravis are well tolerated and reduce symptoms of the disease.
-
Automated Life Science A.I. Generation System Unveiled
A bioengineering lab created a system to make it easier for life scientists to use machine learning for data analysis, without writing their own algorithms.
-
Patent Issued for Synthetic Peptide Chain Techniques
A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins.
-
Biotech Start-Up to Discover Cystic Fibrosis Therapy
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder.
-
Synthetic Bio Company Manufactures Research Cells
A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality.